Time to Benefit and Harm of Direct Oral Anticoagulants in Device-Detected Atrial Fibrillation: A Pooled Analysis of the NOAH-AFNET 6 and ARTESiA Trials

By sjmartinez • June 27, 2024

Huang C, Li L, Liu W, Fang Y, Jiang S, Li Y, Fonarow GC, Sia CH, Yeo LLL, Tan BYQ, Lip GYH, Yang Q, Zhou X. Time to Benefit and Harm of Direct Oral Anticoagulants in Device-Detected Atrial Fibrillation: A Pooled Analysis of the NOAH-AFNET 6 and ARTESiA Trials. Heart Rhythm. 2024 Jun 24:S1547-5271(24)02812-1. doi: 10.1016/j.hrthm.2024.06.038. Epub ahead of print. PMID: 38925332.

Tags: AHREs, Cardiology/Epi, DOACs, Publications, Time to benefit, time to harm

Cardiovascular Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease

Wang DR, Famini P, Shamsa K. Cardiovascular Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease. J Clin Gastroenterol. 2025 Jun 9. doi: 10.1097/MCG.0000000000002176. Epub ahead of[...]

Mid- to Late-Life Traditional Cardiovascular Risk Factor Exposure and Zero Coronary Artery Calcium: The ARIC (Atherosclerosis Risk in Communities) Study

Wang FM, Ballew SH, Folsom AR, Wagenknecht LE, Howard CM, Coresh J, Budoff MJ, Blaha MJ, Matsushita K. Mid- to Late-Life Traditional Cardiovascular Risk Factor[...]

South Asians and cardiometabolic health: A framework for comprehensive care for the individual, community, and population – An American society for preventive cardiology clinical practice statement

Rohatgi A, Anand SS, Gadgil M, Gujral UP, Jain SS, Javed Z, Jha M, Joshi PH, Manubolu VS, Nasir K, Natarajan P, Pagidipati N, Palaniappan[...]